Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer EntitiesWolfgang P. Fendler, Rainer Hamacher, Manuel Weber et al.|Clinical Cancer Research|2022Cited by 145
<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical TherapyHelena Lanzafame, Wolfgang P. Fendler, Marc Ingenwerth et al.|Journal of Nuclear Medicine|2024Cited by 36
Fibroblast Activation Protein Inhibitor TheranosticsRainer Hamacher, Wolfgang P. Fendler, Ken Herrmann et al.|PET Clinics|2023Cited by 14